Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1708 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Million-fold sensitivity enhancement in proteopathic seed amplification assays for biospecimens by Hofmeister ion comparisons

Metrick MA 2nd, do Carmo Ferreira N, Saijo E, Hughson AG, Kraus A, Orrú C, Miller MW, Zanusso G, Ghetti B, Vendruscolo M, Caughey B.

Proc Natl Acad Sci U S A. 2019 Nov 12;116(46):23029-23039. doi: 10.1073/pnas.1909322116. Epub 2019 Oct 22.

Plasma Clusterin as a Potential Biomarker for Alzheimer's Disease-A Systematic Review and Meta-analysis

Shi X, Xie B, Xing Y, Tang Y.

Curr Alzheimer Res. 2019;16(11):1018-1027. doi: 10.2174/1567205016666191024141757.

Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific Cytokinome Signature

Boccardi V, Paolacci L, Remondini D, Giampieri E, Poli G, Curti N, Cecchetti R, Villa A, Ruggiero C, Brancorsini S, Mecocci P.

J Alzheimers Dis. 2019;72(3):911-918. doi: 10.3233/JAD-190480.

Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer's disease

Kenny A, Jiménez-Mateos EM, Zea-Sevilla MA, Rábano A, Gili-Manzanaro P, Prehn JHM, Henshall DC, Ávila J, Engel T, Hernández F.

Sci Rep. 2019 Oct 28;9(1):15437. doi: 10.1038/s41598-019-51837-y.

When Does Alzheimer's Disease Really Start? The Role of Biomarkers

Lloret A, Esteve D, Lloret MA, Cervera-Ferri A, Lopez B, Nepomuceno M, Monllor P.

Int J Mol Sci. 2019 Nov 6;20(22):5536. doi: 10.3390/ijms20225536.

Fluid biomarker-based molecular phenotyping of Alzheimer's disease patients in research and clinical settings

Blennow K, Zetterberg H.

Prog Mol Biol Transl Sci. 2019;168:3-23. doi: 10.1016/bs.pmbts.2019.07.006. Epub 2019 Jul 24.

The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey

Lam J, Hlávka J, Mattke S.

J Am Board Fam Med. 2019 Nov-Dec;32(6):931-940. doi: 10.3122/jabfm.2019.06.180328.

Genetic Markers of Alzheimer's Disease

Nikolac Perkovic M, Pivac N.

Adv Exp Med Biol. 2019;1192:27-52. doi: 10.1007/978-981-32-9721-0_3.

Macroalgae as a Valuable Source of Naturally Occurring Bioactive Compounds for the Treatment of Alzheimer's Disease

Olasehinde TA, Olaniran AO, Okoh AI.

Mar Drugs. 2019 Oct 25;17(11):609. doi: 10.3390/md17110609.

Neutral Endopeptidase (Neprilysin) in Therapy and Diagnostics: Yin and Yang

Feygina EE, Katrukha AG, Semenov AG.

Biochemistry (Mosc). 2019 Nov;84(11):1346-1358. doi: 10.1134/S0006297919110105.

Functional Connectivity in Neurodegenerative Disorders: Alzheimer's Disease and Frontotemporal Dementia

Jalilianhasanpour R, Beheshtian E, Sherbaf G, Sahraian S, Sair HI.

Top Magn Reson Imaging. 2019 Dec;28(6):317-324. doi: 10.1097/RMR.0000000000000223.

Oxidative Damage of DNA as Early Marker of Alzheimer's Disease

Peña-Bautista C, Tirle T, López-Nogueroles M, Vento M, Baquero M, Cháfer-Pericás C.

Int J Mol Sci. 2019 Dec 5;20(24):6136. doi: 10.3390/ijms20246136.

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer's disease

Barichello T, Giridharan VV, Dal-Pizzol F.

Braz J Psychiatry. 2019 Nov-Dec;41(6):467-468. doi: 10.1590/1516-4446-2019-0629.

Dementia is not synonymous with Alzheimer's disease

Jack CR Jr, Holtzman DM, Sperling R.

Sci Transl Med. 2019 Dec 11;11(522):eaav0511. doi: 10.1126/scitranslmed.aav0511.

Cerebrospinal fluid and blood Aβ levels in Down syndrome patients with and without dementia: a meta-analysis study

Du Y, Chen L, Jiao Y, Cheng Y.

Aging (Albany NY). 2019 Dec 20;11(24):12202-12212. doi: 10.18632/aging.102560. Epub 2019 Dec 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias